SCHEMBL19555797

SCHEMBL19555797

O=C(O)NC12CC(C(=O)NNC(=O)COc3ccc(Cl)cc3)(C1)C2

nearest known ligand 0.65

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ ATF4 P18848 10/20 0.65
▸ KMT2A Q03164 2/20 0.49
▸ ADAMTS5 Q9UNA0 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19556192 0.85 ATF4 (0.89) ATF4KMT2AMEN1NPC1TSHR
SCHEMBL19555713 0.84 ATF4 (0.58) ATF4
SCHEMBL31501042 0.84 ATF4 (0.57) ATF4KMT2AKDM4EMEN1NPC1
SCHEMBL30335856 0.82 ATF4 (0.55) ATF4KMT2AKDM4EMEN1
SCHEMBL20973090 0.82 ATF4 (0.81) ATF4KMT2AMEN1NPC1TSHR
SCHEMBL20722101 0.81 ATF4 (0.75) ATF4KMT2AMEN1NPC1TSHR
SCHEMBL21618348 0.80 ATF4 (0.65) ATF4KMT2AADAMTS5KDM4EMEN1
SCHEMBL20974142 0.80 ATF4 (1.00) ATF4KMT2AMEN1NPC1TSHR
SCHEMBL19555682 0.78 ATF4 (0.70) ATF4KMT2AKDM4EMEN1NPC1
SCHEMBL30446215 0.78 ATF4 (0.79) ATF4KMT2AMEN1NPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704098-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2024-01-24 — — EP disclosed
US-20230144871-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2023-05-11 — — US disclosed
US-20210113532-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2021-04-22 — — US disclosed
EP-3778575-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2021-02-17 — — EP disclosed
US-10864196-B2 Modulators of the integrated stress pathway CALICO LIFE SCIENCES, LLC (US) 2020-12-15 — — US disclosed
US-20200361881-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2020-11-19 — — US disclosed
EP-3704098-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2020-09-09 — — EP disclosed
EP-3452454-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2020-07-08 — — EP disclosed
US-20190142806-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2019-05-16 — — US disclosed
EP-3452454-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2019-03-13 — — EP disclosed
WO-2017193030-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES (US) 2017-11-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190142806-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 ATF4 1/4885KMT2A 4320/4885ADAMTS5 4728/4885
US-20230144871-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 ATF4 1/4885KMT2A 4320/4885ADAMTS5 4728/4885
US-20210113532-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 ATF4 1/4885KMT2A 4320/4885ADAMTS5 4728/4885
US-20200361881-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 ATF4 1/4885KMT2A 4320/4885ADAMTS5 4728/4885
US-10864196-B2 Modulators of the integrated stress pathway ATF4, ATF1, DDIT3 ATF4 1/4885KMT2A 4320/4885ADAMTS5 4728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback